Trial Profile
An Open Label Interventional Phase 4 Study to Evaluate Efficacy, Safety and Mucosal Healing of Early Versus Late Use of Vedolizumab in Ulcerative Colitis: the LOVE-UC Study (LOw Countries VEdolizumab in UC Study)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Acronyms LOVE-UC
- 23 May 2021 Primary endpoint (Clinical and endoscopic remission) has not been met, according to Results presented at the Digestive Disease Week 2021.
- 23 May 2021 Results presented at the Digestive Disease Week 2021.
- 07 Oct 2020 Status changed from recruiting to completed.